17 September 2018 | Paris, France
Hero Image
17 September 2018
Paris, France
Gene Therapy Partnering Day


After the succes of REGMED Europe in 2017 ( https://www.b2match.eu/regmedp...) the Imagine Institute, Medicen Paris Region and Paris Region are delighted to invite you to the first international partnering event focused on gene therapy, held at the Imagine Institute, in Paris on September 17th, 2018.

This one-day international matchmaking event aims to foster future public-private or public-public R&D collaborations by leveraging the complementarity of expertise and resources from academic researchers, clinicians, and biotech/medtech companies offering innovative technological solutions for gene therapy.

Why participate?

  • Meet the main European actors in your field and build international partnerships
  • Learn about the major challenges facing gene therapy
  • Get the chance to present your innovative projects and technical solutions
  • Get in-depth information about the ongoing gene therapy research projects led by Paris-Region academic groups under the “DIM Thérapie génique” initiative

Target audience

  • Biotech/Medtech and Pharma companies
  • Academic researchers and clinical doctors
  • European Life sciences clusters

Main topics

  • Challenges in the field of Gene Therapy
  • Pitch of European Biotech/Medtech companies
  • Afternoon Partnering session
  • Pitch of ongoing research projects led by academic teams of the Paris Region under the “DIM Thérapie génique” initiative
  • Pitch of European Biotech/Medtech companies 
  • Afternoon Partnering session


Free of charge

Supported by



Closed since 31 July 2018


Imagine - Institut des Maladies Génétiques
Boulevard du Montparnasse 24
75015 Paris, France

Organised by


Participants 99
Meetings 126


Australia 1
Belgium 8
France 102
Germany 2
Israel 1
Italy 1
Netherlands 14
Spain 2
Switzerland 2
Turks And Caicos Islands 1
United Kingdom 4
United States 4
Total 142


Large Company 20
SME 39
University 11
Hospital 10
R&D Institution 28
Cluster/Association/Agency 9
Authority/Government 5
Investor 6
Technology Transfer Organization 8
Consulting 6
Total 142